Prevalence of Visual Acuity Loss or Blindness in the US: A Bayesian Meta-analysis.

Prevalence of Visual Acuity Loss or Blindness in the US: A Bayesian Meta-analysis.
复制标题

DOI:
10.1001/jamaophthalmol.2021.0527
复制
发表时间:
2021-07-01
期刊:
影响因子:
8.1
通讯作者:
Vision and Eye Health Surveillance System study group
Vision and Eye Health Surveillance System study group
中科院分区:
医学1区
文献类型:
--
作者:
Flaxman AD;Wittenborn JS;Robalik T;Gulia R;Gerzoff RB;Lundeen EA;Saaddine J;Rein DB;Vision and Eye Health Surveillance System study group

文献摘要

参考文献

被引文献

相似文献

美国有多少人患有无法矫正的视力丧失或失明?这项评估的荟萃分析估计,2017年有708万人患有视力丧失,其中108万人患有失明。根据这项研究,不可矫正的视力丧失和失明是美国健康负担的更大驱动因素,比以前已知的更大。这项荟萃分析结合了基于人群的调查和来自美国疾病控制和预防中心视力和眼健康监测系统的数据,以按年龄、性别、种族/民族和美国州对视力丧失和失明进行估计。在全球范围内,超过2.5亿人患有视力丧失或失明,美国人担心失去视力超过记忆,听力或语言。但最近似乎没有关于美国视力丧失或失明的经验估计。按年龄、性别、人种/种族和美国各州估计视力丧失和失明。数据来自美国社区调查(2017年),国家健康和营养检查调查(1999-2008年),全国儿童健康调查(2017年)以及基于人口的研究(2000-2013年)。所有相关数据均来自美国疾病控制和预防中心的视力和眼睛健康监测系统。估计视力丧失或失明的患病率,并在可能的情况下按美国州、年龄组、性别、人种/种族和社区居住或群体居住状态等因素分层。数据分析时间为2018年3月至2020年3月。视力较好眼的视力丧失(定义为最佳矫正视力≥ 0.3 logMAR)和失明(定义为logMAR ≥ 1.0)的患病率。2017年,这项荟萃分析估计美国有708万(95%不确定区间,632 - 789)人患有视力丧失,其中108万(95%不确定区间,082 - 130)人患有失明。其中,162万(95%不确定区间,132 - 192)视力丧失者年龄小于40岁,141 000(95%不确定区间,95 000-187 000)失明者年龄小于40岁。用现代方法对所有现有数据进行分析,得出的估计数大大高于以前公布的估计数。
How many people in the US are living with uncorrectable visual acuity loss or blindness? This bayesian meta-analysis generated an estimate that, in 2017, there were 7.08 million people living with visual acuity loss, of whom 1.08 million were living with blindness. Per this study, uncorrectable visual acuity loss and blindness are even larger drivers of health burden in the US than was previously known. This meta-analysis combines population-based surveys and data from the US Centers for Disease Control and Prevention’s Vision and Eye Health Surveillance System to produce estimates of visual acuity loss and blindness by age, sex, race/ethnicity, and US state. Globally, more than 250 million people live with visual acuity loss or blindness, and people in the US fear losing vision more than memory, hearing, or speech. But it appears there are no recent empirical estimates of visual acuity loss or blindness for the US. To produce estimates of visual acuity loss and blindness by age, sex, race/ethnicity, and US state. Data from the American Community Survey (2017), National Health and Nutrition Examination Survey (1999-2008), and National Survey of Children’s Health (2017), as well as population-based studies (2000-2013), were included. All relevant data from the US Centers for Disease Control and Prevention’s Vision and Eye Health Surveillance System were included. The prevalence of visual acuity loss or blindness was estimated, stratified when possible by factors including US state, age group, sex, race/ethnicity, and community-dwelling or group-quarters status. Data analysis occurred from March 2018 to March 2020. The prevalence of visual acuity loss (defined as a best-corrected visual acuity greater than or equal to 0.3 logMAR) and blindness (defined as a logMAR of 1.0 or greater) in the better-seeing eye. For 2017, this meta-analysis generated an estimated US prevalence of 7.08 (95% uncertainty interval, 6.32-7.89) million people living with visual acuity loss, of whom 1.08 (95% uncertainty interval, 0.82-1.30) million people were living with blindness. Of this, 1.62 (95% uncertainty interval, 1.32-1.92) million persons with visual acuity loss are younger than 40 years, and 141 000 (95% uncertainty interval, 95 000-187 000) persons with blindness are younger than 40 years. This analysis of all available data with modern methods produced estimates substantially higher than those previously published.
DOI: 10.3109/09286586.2015.1066395
发表时间: 2015
影响因子: 1.8
作者:
Fisher DE;Shrager S;Shea SJ;Burke GL;Klein R;Wong TY;Klein BE;Cotch MF
通讯作者: Cotch MF
DOI: 10.1001/jamaophthalmol.2016.1284
发表时间: 2016-07-01
期刊: JAMA OPHTHALMOLOGY
影响因子: 8.1
作者:
Varma, Rohit;Vajaranant, Thasarat S.;Burkemper, Bruce;Wu, Shuang;Torres, Mina;Hsu, Chunyi;Choudhury, Farzana;McKean-Cowdin, Roberta
通讯作者: McKean-Cowdin, Roberta
DOI: 10.1001/jamaophthalmol.2016.2627
发表时间: 2016-10-01
期刊: JAMA OPHTHALMOLOGY
影响因子: 8.1
作者:
Scott, Adrienne W.;Bressler, Neil M.;Jorkasky, James
通讯作者: Jorkasky, James
DOI: 10.1001/jama.2012.85685
发表时间: 2012-12-12
影响因子: 120.7
作者:
Ko, Fang;Vitale, Susan;Chou, Chiu-Fang;Cotch, Mary Frances;Saaddine, Jinan;Friedman, David S.
通讯作者: Friedman, David S.
DOI: 10.1080/09286586.2016.1193207
发表时间: 2016-08
影响因子: 1.8
作者:
Pleet A;Sulewski M;Salowe RJ;Fertig R;Salinas J;Rhodes A;Merritt Iii W;Natesh V;Huang J;Gudiseva HV;Collins DW;Chavali VR;Tapino P;Lehman A;Regina-Gigiliotti M;Miller-Ellis E;Sankar P;Ying GS;O'Brien JM
通讯作者: O'Brien JM